Nuveen Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $423M | Buy |
|
|||||
|
2024
Q3 | $367M | Sell |
|
|||||
|
2024
Q2 | $377M | Sell |
|
|||||
|
2024
Q1 | $349M | Sell |
|
|||||
|
2023
Q4 | $342M | Buy |
|
|||||
|
2023
Q3 | $283M | Sell |
|
|||||
|
2023
Q2 | $300M | Sell |
|
|||||
|
2023
Q1 | $286M | Sell |
|
|||||
|
2022
Q4 | $263M | Sell |
|
|||||
|
2022
Q3 | $386M | Buy |
|
|||||
|
2022
Q2 | $353M | Sell |
|
|||||
|
2022
Q1 | $315M | Sell |
|
|||||
|
2021
Q4 | $295M | Sell |
|
|||||
|
2021
Q3 | $248M | Sell |
|
|||||
|
2021
Q2 | $566M | Buy |
|
|||||
|
2021
Q1 | $590M | Buy |
|
|||||
|
2020
Q4 | $620M | Sell |
|
|||||
|
2020
Q3 | $953M | Buy |
|
|||||
|
2020
Q2 | $1.01B | Buy |
|
|||||
|
2020
Q1 | $655M | Buy |
|
|||||
|
2019
Q4 | $550M | Buy |
|
|||||
|
2019
Q3 | $350M | Sell |
|
|||||
|
2019
Q2 | $423M | Buy |
|
|||||
|
2019
Q1 | $2.82M | Sell |
|
|||||
|
2018
Q4 | $2.54M | Sell |
|
|||||
|
2018
Q3 | $2.98M | Sell |
|
|||||
|
2018
Q2 | $2.71M | Sell |
|
|||||
|
2018
Q1 | $2.99M | Sell |
|
|||||
|
2017
Q4 | $4.11M | Sell |
|
|||||
|
2017
Q3 | $13.5M | Sell |
|
|||||
|
2017
Q2 | $15.5M | Buy |
|
|||||
|
2017
Q1 | $7.3M | Buy |
|
|||||
|
2016
Q4 | $4.18M | Sell |
|
|||||
|
2016
Q3 | $15.9M | Buy |
|
|||||
|
2016
Q2 | $13.6M | Buy |
|
|||||
|
2016
Q1 | $1.27K | Sell |
|
|||||
|
2015
Q4 | $2.03K | Sell |
|
|||||
|
2015
Q3 | $1.78K | Buy |
|
|||||
|
2015
Q2 | $2.03K | Sell |
|
|||||
|
2015
Q1 | $5.4M | Sell |
|
|||||
|
2014
Q4 | $13.3M | Sell |
|
|||||
|
2014
Q3 | $26.9M | Buy |
|
|||||
|
2014
Q2 | $18.7M | Buy |
|
|||||
|
2014
Q1 | $2.63M | Sell |
|
|||||
|
2013
Q4 | $2.8M | Sell |
|
|||||
|
2013
Q3 | $2.86M | Sell |
|
|||||
|
2013
Q2 | $8.15M | Buy |
|